Polycystic kidney disease and the renal cilium (Review Article)

Nephrology

Volumn 12, Issue 6, 2007, Pages 559-564

  Deane, James A ^a   Ricardo, Sharon D ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Cellular proliferation; Cilium; Epithelial cell; Polycystic kidney disease; Polycystin

Indexed keywords

POLYCYSTIN; RAPAMYCIN; ROSCOVITINE; SOMATOSTATIN DERIVATIVE; TRIPTOLIDE; VASOPRESSIN ANTAGONIST;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CALCIUM SIGNALING; CELL PROLIFERATION; CILIATED EPITHELIUM; EPITHELIUM CELL; HUMAN; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; MOLECULAR SENSOR; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

CELL PROLIFERATION; CILIA; GENES, DOMINANT; GENES, RECESSIVE; HUMANS; POLYCYSTIC KIDNEY DISEASES;

EID: 35848968881     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00869.x     Document Type: Review

References (64)

1. Chang MY, Parker E, Ibrahim S et al. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models. Nephrol. Dial. Transplant. 2006 21 : 2078 84.
2. Nadasdy T, Laszik Z, Lajoie G, Blick KE, Wheeler DE, Silva FG. Proliferative activity of cyst epithelium in human renal cystic diseases. J. Am. Soc. Nephrol. 1995 5 : 1462 8.
3. Sullivan LP, Wallace DP, Grantham JJ. Epithelial transport in polycystic kidney disease. Physiol. Rev. 1998 78 : 1165 91.
4. Silberberg M, Charron AJ, Bacallao R, Wandinger-Ness A. Mispolarization of desmosomal proteins and altered intercellular adhesion in autosomal dominant polycystic kidney disease. Am. J. Physiol. Renal Physiol. 2005 288 : F1153 63.
5. Gabow PA. Autosomal dominant polycystic kidney disease. N. Engl. J. Med. 1993 329 : 332 42.
6. The International Polycystic Kidney Disease Consortium. Polycystic kidney disease: The complete structure of the PKD1 gene and its protein. Cell 1995 81 : 289 98.
7. Mochizuki T, Wu G, Hayashi T et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996 272 : 1339 42.
8. Harris PC, Rossetti S. Molecular genetics of autosomal recessive polycystic kidney disease. Mol. Genet. Metab. 2004 81 : 75 85.
9. Bergmann C, Senderek J, Sedlacek B et al. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J. Am. Soc. Nephrol. 2003 14 : 76 89.
10. Onuchic LF, Furu L, Nagasawa Y et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet. 2002 70 : 1305 17.
11. Guay-Woodford LM. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am. J. Physiol. Renal Physiol. 2003 285 : F1034 49.
12. Pazour GJ, Dickert BL, Vucica Y et al. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J. Cell Biol. 2000 151 : 709 18.
13. Yoder BK, Tousson A, Millican L et al. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am. J. Physiol. Renal Physiol. 2002 282 : F541 52.
14. Webber WA, Lee J. Fine structure of mammalian renal cilia. Anat. Rec. 1975 182 : 339 43.
15. Wheatley DN, Wang AM, Strugnell GE. Expression of primary cilia in mammalian cells. Cell Biol. Int. 1996 20 : 73 81.
16. Barr MM, Sternberg PW. A polycystic kidney-disease gene homologue required for male mating behaviour in C. elegans. Nature 1999 401 : 386 9.
17. Moyer JH, Lee-Tischler MJ, Kwon HY et al. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 1994 264 : 1329 33.
18. Lin F, Hiesberger T, Cordes K et al. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc. Natl. Acad. Sci. USA 2003 100 : 5286 91.
19. Torres VE, Harris PC. Mechanisms of disease: Autosomal dominant and recessive polycystic kidney diseases. Nat. Clin. Pract. Nephrol. 2006 2 : 40 55 quiz 55.
20. Pazour GJ, San Agustin JT, Follit JA, Rosenbaum JL, Witman GB. Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr. Biol. 2002 12 : R378 80.
21. Yoder BK, Hou X, Guay-Woodford LM. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J. Am. Soc. Nephrol. 2002 13 : 2508 16.
22. Ward CJ, Yuan D, Masyuk TV et al. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum. Mol. Genet. 2003 12 : 2703 10.
23. Wang S, Luo Y, Wilson PD, Witman GB, Zhou J. The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area. J. Am. Soc. Nephrol. 2004 15 : 592 602.
24. Pazour GJ. Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease. J. Am. Soc. Nephrol. 2004 15 : 2528 36.
25. Nauli SM, Alenghat FJ, Luo Y et al. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 2003 33 : 129 37.
26. Babich V, Zeng WZ, Yeh BI et al. The N-terminal extracellular domain is required for polycystin-1-dependent channel activity. J. Biol. Chem. 2004 279 : 25582 9.
27. Forman JR, Qamar S, Paci E, Sandford RN, Clarke J. The remarkable mechanical strength of polycystin-1 supports a direct role in mechanotransduction. J. Mol. Biol. 2005 349 : 861 71.
28. Xu GM, Gonzalez-Perrett S, Essafi M et al. Polycystin-1 activates and stabilizes the polycystin-2 channel. J. Biol. Chem. 2003 278 : 1457 62.
29. Puri S, Magenheimer BS, Maser RL et al. Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway. J. Biol. Chem. 2004 279 : 55455 64.
30. Belibi FA, Reif G, Wallace DP et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004 66 : 964 73.
31. Yamaguchi T, Hempson SJ, Reif GA, Hedge AM, Wallace DP. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J. Am. Soc. Nephrol. 2006 17 : 178 87.
32. Chauvet V, Tian X, Husson H et al. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J. Clin. Invest. 2004 114 : 1433 43.
33. Low SH, Vasanth S, Larson CH et al. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev. Cell 2006 10 : 57 69.
34. Shillingford JM, Murcia NS, Larson CH et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl. Acad. Sci. USA 2006 103 : 5466 71.
35. Bhunia AK, Piontek K, Boletta A et al. PKD1 induces p21 (waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002 109 : 157 68.
36. Simons M, Gloy J, Ganner A et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 2005 37 : 537 43.
37. Simons M, Walz G. Polycystic kidney disease: Cell division without a c(l)ue? Kidney Int. 2006 70 : 854 64.
38. Yoder BK, Mulroy S, Eustace H, Boucher C, Sandford R. Molecular pathogenesis of autosomal dominant polycystic kidney disease. Expert Rev. Mol. Med. 2006 8 : 1 22.
39. Qian F, Watnick TJ. Somatic mutation as mechanism for cyst formation in autosomal dominant polycystic kidney disease. Mol. Genet. Metab. 1999 68 : 237 42.
40. Qian F, Watnick TJ, Onuchic LF, Germino GG. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell 1996 87 : 979 87.
41. Pei Y, Watnick T, He N et al. Somatic PKD2 mutations in individual kidney and liver cysts support a 'two-hit' model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 1999 10 : 1524 9.
42. Boulter C, Mulroy S, Webb S, Fleming S, Brindle K, Sandford R. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc. Natl. Acad. Sci. USA 2001 98 : 12174 9.
43. Lu W, Shen X, Pavlova A et al. Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum. Mol. Genet. 2001 10 : 2385 96.
44. Wu G, D'Agati V, Cai Y et al. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 1998 93 : 177 88.
45. Jiang ST, Chiou YY, Wang E et al. Defining a link with autosomal-dominant polycystic kidney disease in mice withcongenitally low expression of Pkd1. Am. J. Pathol. 2006 168 : 205 20.
46. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ et al. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 2004 13 : 3069 77.
47. Gallagher AR, Hoffmann S, Brown N et al. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats. J. Am. Soc. Nephrol. 2006 17 : 2719 30.
48. Menezes LF, Cai Y, Nagasawa Y et al. Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm. Kidney Int. 2004 66 : 1345 55.
49. Ward CJ, Hogan MC, Rossetti S et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 2002 30 : 259 69.
50. Hiesberger T, Gourley E, Erickson A et al. Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C. J. Biol. Chem. 2006 281 : 34357 64.
51. Saunier S, Salomon R, Antignac C. Nephronophthisis. Curr. Opin. Genet. Dev. 2005 15 : 324 31.
52. Sayer JA, Otto EA, O'Toole JF et al. The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat. Genet. 2006 38 : 674 81.
53. Tobin JL, Beales PL. Bardet-Biedl syndrome: beyond the cilium. Pediatr. Nephrol. 2007 22 : 926 36.
54. Streets AJ, Newby LJ, O'Hare MJ, Bukanov NO, Ibraghimov-Beskrovnaya O, Ong AC. Functional analysis of PKD1 transgenic lines reveals a direct role for polycystin-1 in mediating cell-cell adhesion. J. Am. Soc. Nephrol. 2003 14 : 1804 15.
55. Koulen P, Cai Y, Geng L et al. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 2002 4 : 191 7.
56. Qian Q, Hunter LW, Li M et al. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum. Mol. Genet. 2003 12 : 1875 80.
57. Lo SH, Yu QC, Degenstein L, Chen LB, Fuchs E. Progressive kidney degeneration in mice lacking tensin. J. Cell Biol. 1997 136 : 1349 61.
58. Nakayama K, Negishi I, Kuida K, Sawa H, Loh DY. Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 1994 91 : 3700 4.
59. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993 75 : 229 40.
60. Hughes P, Robati M, Lu W, Zhou J, Strasser A, Bouillet P. Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms. Cell Death Differ. 2006 13 : 1123 7.
61. Gattone VH 2nd. Emerging therapies for polycystic kidney disease. Curr. Opin. Pharmacol. 2005 5 : 535 42.
62. Ruggenenti P, Remuzzi A, Ondei P et al. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 2005 68 : 206 16.
63. Bukanov NO, Smith LA, Klinger KW, Ledbetter SR, Ibraghimov-Beskrovnaya O. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 2006 444 : 949 52.
64. Leuenroth SJ, Okuhara D, Shotwell JD et al. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc. Natl. Acad. Sci. USA 2007 104 : 4389 94.